BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5263293)

  • 21. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologic properties of methylcholanthrene-induced sarcomas of neonatally thymectomized mice.
    Nomoto K; Takeya K
    J Natl Cancer Inst; 1969 Mar; 42(3):445-53. PubMed ID: 5779635
    [No Abstract]   [Full Text] [Related]  

  • 23. Antigenicity of carcinogen and viral induced sarcomas in inbred and random bred guinea pigs.
    Forni G; Rhim JS; Pickeral S; Shevach EM; Green I
    J Immunol; 1975 Jul; 115(1):204-10. PubMed ID: 50348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activation of virus-like particles from chemically induced Guinea pig sarcomas.
    Winters WD; Boddie AW; Roth JA; Adams JM
    Proc Soc Exp Biol Med; 1975 Jul; 149(3):714-22. PubMed ID: 806925
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW; Pimm MV
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract]   [Full Text] [Related]  

  • 27. The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas.
    Pilch YH
    Cancer Res; 1968 Dec; 28(12):2502-11. PubMed ID: 4302533
    [No Abstract]   [Full Text] [Related]  

  • 28. CHANGES OF TRANSPLANTATION CHARACTERISTICS IN METHYLCHOLANTHRENE-INDUCED TUMOURS. ISOLATION OF SPECIFIC ISOANTIGENIC VARIANTS.
    KLEIN J
    Neoplasma; 1965; 12():125-30. PubMed ID: 14320330
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfer of tumor-specific immunity with RNA: demonstration by immune cytolysis of tumor cells in vitro.
    Ramming KP; Pilch YH
    J Natl Cancer Inst; 1970 Sep; 45(3):543-53. PubMed ID: 5523195
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
    Baldwin RW; Glaves D; Pimm MV; Vose BM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of immunization with an allogeneic tumor on the growth of primary methylcholanthrene-induced sarcomas in rats.
    Usubuchi I; Kudo H; Kano M; Suga M
    Tohoku J Exp Med; 1976 May; 119(1):79-83. PubMed ID: 951705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1969 Oct; 29(10):1814-20. PubMed ID: 5823950
    [No Abstract]   [Full Text] [Related]  

  • 33. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; LavrovskiÄ­ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene-induced sarcomas.
    Law LW
    Int J Cancer; 1984 Apr; 33(4):547-51. PubMed ID: 6200449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma].
    Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K
    Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitory effect of cross-immunity on autotransplantation of methylcholanthrene-induced rat sarcomas.
    Usubuchi I; Kudo H; Sobajima Y; Sato T; Kakisaka Y
    Tohoku J Exp Med; 1973 Jun; 110(2):155-60. PubMed ID: 4729241
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
    Natori T; Law LW; Appella E
    Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribonucleic acid-mediated inhibition and enhancement of tumor growth in mice.
    Ramming KP; Pilch YH
    Surg Forum; 1969; 20():106-9. PubMed ID: 5383020
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 40. Efferent enhancement of a methylcholanthrene-induced sarcoma transplantable in strain 13 guinea pigs.
    Berczi I; Tsay HM; Sehon AH
    Eur J Immunol; 1976 Jun; 6(6):453-5. PubMed ID: 991912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.